SINK SIDE
NOTESSKIN-CARE DECISIONPRACTICAL CALL

U.S. ROUTINE CONTEXT · PRACTICAL CALL

Tell post-blemish marks, sun spots, and possible melasma apart before buying

Avoid choosing a dark-spot product before clarifying what kind of color change is being addressed.

NOTE 01

OUR SINK-SIDE CALL

The route we would take.

Start with consistent sun protection before brightening

NOTE 02

Where the call changes.

CHOOSE DIFFERENTLY WHEN

  • A lesion or possible melasma should not be self-diagnosed from a product page.
  • Irritating brightening products can worsen the appearance they were meant to improve.

WHAT WE ARE NOT CLAIMING

  • The full protocol, comparator, primary criteria, sample size and profile, dispersion, and complete report are often not public.

NOTE 03

HOW TO READ THIS NOTE

Evidence without theater.

This page makes an editorial call from documented context. It does not claim a product was owned, used, ranked, or independently tested. Manufacturer statements never become our results.

EVIDENCE TRAIL

What the sources carry — and what the desk decides.

The linked sources support product status, labeling, or professional boundaries. They do not prove the editorial winner and they do not stand in for an owned test.

EDITORIAL JUDGMENT

Start with consistent sun protection before brightening

A reasoned course of action; not a product result measured by the source.
BOUNDARY OF THE CALL

A lesion or possible melasma should not be self-diagnosed from a product page.

The full protocol, comparator, primary criteria, sample size and profile, dispersion, and complete report are often not public.

Primary and professional sources in the record

  1. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)U.S. Food and Drug Administration
  2. Cosmetics Labeling ClaimsU.S. Food and Drug Administration
  3. Summary of Cosmetics Labeling RequirementsU.S. Food and Drug Administration
  4. 21 CFR Part 701 — Cosmetic LabelingOffice of the Federal Register / eCFR
  5. Final Administrative Order OTC000039 — M020 Sunscreen Drug ProductsU.S. Food and Drug Administration
  6. 21 CFR 201.327 — OTC sunscreen labeling and effectiveness testingOffice of the Federal Register / eCFR
  7. Sunscreen: How to Help Protect Your Skin from the SunU.S. Food and Drug Administration
  8. Health Products Compliance GuidanceU.S. Federal Trade Commission
Data and test conditions still required
Product function and category

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Ingredient list for the current version

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Standardized photography conditions

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Shade, undertone, and documented swatch

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

SPF and UVA protection

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Evidence for the specific claim

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Regulatory status and applicable labeling

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Separate cosmetic skin care from medical review

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Document color under standardized light

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Audit sunscreen label and directions

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Trace a general claim to its evidence

Define and retain the conditions, date, material, and outcome before presenting any owned observation.